Most-Viewed Videos from AJMC for the Year 2015

The top 10 videos from The American Journal of Managed Care include highlights from the Stakeholder Summit and Insight programs.

10. Appropriate, Value-Based Care in Immuno-Oncology

During a discussion on immuno-oncology agents, Andrew L. Pecora, MD, shares his thoughts on important considerations for payers and providers as they contemplate about value in oncology care.

9. Palliative Care and Healthcare Utilization

Does palliative care impact healthcare utilization? Can a pharmacist play a role with integrating palliative care early in the treatment plan? Genevieve Kumapley, PharmD, BCOP, provided insight to help answer these and other questions about palliative care.

8. Spring Healthcare Reform Stakeholders Summit: Accountable Care Organizations and Risk

During the Healthcare Reform Stakeholders Summit, Francois de Brantes, MS, MBA; Ateev Mehrotra, MD, MPH; and Arthur Vercillo, MD, FACS, discuss new risk sharing models for participating stakeholders that are emerging out of accountable care organizations.

7. Palliative Care Planning

A palliative care plan should be a collective effort of the patient, the provider of care, and the patient’s family. Introducing the available options to both the patient and the family can help them make informed decisions that reflect what the patient expects from end-of-life care, according to Bruce A. Feinberg, DO, and Brian B. Kiss, MD.

6. Quality of Life Metrics in Palliative Care

Do oral oncolytics find a place in the palliative care plan of cancer patients? Can their use be defined by specific quality-of-life (QoL) metrics? Bruce A. Feinberg, DO, and Brian B. Kiss, MD, reviewed important considerations when identifying these QoL metrics.

5. Spring Healthcare Reform Stakeholders Summit: Actuarial Considerations in Consumer-Directed Healthcare

During the Healthcare Reform Stakeholders Summit, Francois de Brantes, MS, MBA; Ateev Mehrotra, MD, MPH; and Arthur Vercillo, MD, FACS, deliberated the costs and the complexity of insurance design and how it could affect patients.

4. Spring Healthcare Reform Stakeholders Summit: The Healthcare System Future

Francois de Brantes, MS, MBA; Ateev Mehrotra, MD, MPH; and Arthur Vercillo, MD, FACS, discuss the future of healthcare during the Healthcare Reform Stakeholders Summit hosted by The American Journal of Managed Care in Spring 2015.

3. Targeted Therapies and the Sequencing of Immuno-Oncology Drugs

Andrew L. Pecora, MD, describes how the new immuno-oncology agents, namely PD-1, PD-L1, and CTLA-4 inhibitors, work, and explains that the research is ongoing to identify the right biomarker to help distinguish responders.

2. Integrating Immunotherapy in Lung Cancer

Hear insights from Andrew L. Pecora, MD, on treatment for non-small cell lung cancer, including sequencing of the new immunotherapy agents.

1. Applying Personalized Medicine to Impact Outcomes in Different Cancer Types

While personalized medicine is still catching up in other therapeutic areas, it currently has most relevance to cancer. David C. Collymore, MD, MBA, believes that tailored treatment, following genetic testing, can improve cancer outcomes and genetic profiles can also allow for earlier preventive interventions.